1. Home
  2. IMMX vs SPIR Comparison

IMMX vs SPIR Comparison

Compare IMMX & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

N/A

Current Price

$12.24

Market Cap

716.2M

Sector

Health Care

ML Signal

N/A

Logo Spire Global Inc.

SPIR

Spire Global Inc.

N/A

Current Price

$11.48

Market Cap

826.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMX
SPIR
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
716.2M
826.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
IMMX
SPIR
Price
$12.24
$11.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$19.20
$16.40
AVG Volume (30 Days)
1.4M
492.9K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
134.98
EPS
N/A
N/A
Revenue
N/A
$110,451,000.00
Revenue This Year
N/A
$12.31
Revenue Next Year
N/A
$22.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.15
52 Week Low
$1.94
$6.60
52 Week High
$15.10
$25.93

Technical Indicators

Market Signals
Indicator
IMMX
SPIR
Relative Strength Index (RSI) 47.05 38.95
Support Level $7.96 $10.30
Resistance Level $15.10 $15.07
Average True Range (ATR) 0.78 0.64
MACD -0.34 -0.12
Stochastic Oscillator 11.79 18.35

Price Performance

Historical Comparison
IMMX
SPIR

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About SPIR Spire Global Inc.

Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.

Share on Social Networks: